Introduction
Gastric cancer is one of the most common malignant tumors worldwide, with 989,600 new diagnosed cases (8% of the total malignancy) and 738,000 deaths annually (10% of total cancer deaths) (Jemal et al., 2011) . Over 70% of new cases and deaths occur in developing countries. The highest incidence rates are in Eastern Asia (Kamangar et al., 2006) , Eastern Europe, and South America (Jemal et al., 2011) . Half of all gastric cancer patients are from Eastern Asia (463, 000 gastric cancer patients in China alone), and approximately two thirds of all cases occur in developing countries (Choi et al., 2014) . Therefore, the development of novel approaches and effective anticancer strategies is critically needed for prolonged survival of stomach cancer.
Rabdosia rubescens are used in Chinese folk medicine for treatment of esophageal cancer in Taihang Mountains area of China for a long time. In 1970s, Research from Chinese researcher showed Rabdosia rubescens had better effect in the treatment of Gush door cancer, liver cancer and esophagus cancer, and oridonin was one of the most important antitumor active ingredient of Rabdosia rubescens.
Oridonin, molecular formula C 20 H 28 O 6 (Figure 1 ), is a diterpenoid compound. Previous studies have shown that oridonin has anti-tumor activities in vivo and in vitro (Zhou et al., 2007; Lou et al., 2009; Wang et al., 2013) (Ye et al., 2012a; 2012b; Yu et al., 2012; Zang et al., 2012; Liu et al., 2013) , by inducing apoptosis through the mitochondrial pathway (Li et al., 2008; Zhu et al., 2013) or Fas/FasL death signal pathway (Liu et al., 2006) , or by arresting the cell cycle on G 0 /G 1 phase in human breast adenocarcinoma MDA-MB-231 cell (Hsieh et al., 2005) , but G 2 /M phase in human breast adenocarcinoma MCF-7 cell (Cui et al., 2007; Zhang et al., 2013) , human liver hepatocellular carcinoma HepG2 cell (Wang et al., 2010) , Human Pancreatic Carcinoma PANC-1 cell (Qi et al., 2012) , murine fibroblast L929 cells (Cheng et al., 2009 ), Human Laryngeal Carcinoma Cells (Kang et al., 2010 . However, little was known about the cell cycle arrest of oridonin on gastric cancer. Therefore, this paper explored the proliferation inhibition, cell cycle arrest and cell cycle protein expression induced by oridonin on human gastric cancer SGC-7901 cell.
Materials and Methods

Material
Oridonin (>98%) was purchased from National Institutes for Food and Drug Control in China. hydroxycamptothecin (HCPT) was provided by Shanghai Longxiang Biological Medicine Development Co. Ltd. in China, Ltd. MTT (3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) was purchased from the United States Molecular Probe company. RPMI-1640 medium was purchased from GIBCO Company. Dimethyl sulfoxide (DMSO), trypsin, and propidium bromide (PI) were purchased from Sigma. Rabbit polyclonal antiCyclin B1 antibody, anti Cdk1/Cdc2 rabbit polyclonal antibody and alkaline phosphatase-labeled goat anti-rabbit IgG were provided by Beyotime institute of Biotechnology in China.
Cell culture
Human gastric cancer SGC-7901 cell line was obtained from Institute of Tumor Research of Harbin Medicine University (Harbin, China). Cells were cultured in RPMI 1640 medium (Gibco, 31800-022) supplemented with 10% (v/v) fetal bovine serum (Gibco, 10099-141) , 100 U/mL penicillin, 100μg/mL streptomycin and 1 mM L-glutamine at 37℃ in an atmosphere of 5% CO 2 . The medium was renewed two or three times/week. Cells in logarithmic growth phase were used for further experiments.
Cell Viability Assay
Cell viability was measured by the MTT assay, which was based on the conversion of MTT to formazan crystals by mitochonfrial dehydrogenases (Mosmann, 1983) . Briefly, SGC-7901 cells were plated at a density of 1×10 3 cells/well in 96-well plate, which was in 100µL RPMI 1640 medium containing 10% (v/v) fetal bovine serum for 24h incubation. After 24h, 100 μl oridonin solution in different concentrations were added into the wells and adjusted the final concentrations to 3. 125, 6.25, 12.5, 25 , 50 μmol/L, respectively. Similarly, negative group was added into PRMI 1640 and positive control group was HCPT. At the end of 72h incubation, the medium were discarded and 100μL of MTT stock solution (1mg/ mL) were added to each well and the plates were further incubated. Four hours later, DMSO (150μL) was added to each well to solubilize the water-insoluble purple formazan crystals. The amount of MTT-formazan is directly proportional to the number of living cells and was determined by measuring the optical density (OD) at 570nm using microplate reader (Bio-Rad). The percentage of cytotoxic activity compared to the untreated cells was determined using the following equation: 4℃ overnight. Finally, the cells were treated with 50μM PI in 37℃ for 0.5h and detected by flow cytometry (excitation wavelength 488nm, emission wavelength of 525nm) (Choi et al., 2007) .
Western blot assay
5 ml/well (2×10 5 cells/ml) SGC-7901 suspensions were added into 150 ml flask, cultured for 24h. Then, oridonin in different concentrations were added into the flasks and cultured for 48h. After 48h, the cells were collected, and proteins were extracted with lysis buffer [50mM TrisCl, pH 8.0, 120mM NaCl, 50mM NaF, 200μM sodium vanadate, 0.5% NP-40, 10 mM phenylmethylsulfonyl fluoride (PMSF), 2μg/mL aprotinin 0.2 μL, 10μg/mL Leupeptin 10μL], and then the cells were centrifuged at 12000×g for 10min at 4℃, the supernatant was saved in -80℃. The protein concentration of the supernatant was detected by Bradford assay. The protein samples were separated by SDS-PAGE and then transferred to the NC membrane with TBST containing 5% skim milk at room temperature for 2h, and the membranes were incubated with the primary antibodies overnight at 4℃. Next day, TBST solution sufficiently washed the membrane for 10 Flow cytometry assay 1 ml/well (1×10 5 cells /ml) SGC-7901 cell suspension was added into 6-well plate and cultured for 24h at 37℃ in an atmosphere of 5% CO 2 . After 24h, oridonin in different concentrations were added into the wells and cultured for 48h. Then, 70% cold ethanol fixed the collected cells in 
Statistical analysis
All the data was represented as the mean±SD. Statistical significance was calculated using student's t-test. P-values of 5% or less were considered statistically significant.
Results
Effect of Oridonin on SGC-7901 Cell Viability
In ordor to evaluate the effect of oridonin on proliferation of the SGC-7901 cell, the cells were treated with different concentrations of oridonin for 72h, the impact of oridonin on cell viability was quantitated by MTT assay. The results showed that oridonin could inhibit the proliferation of SGC-7901 cell, and the IC 50 of oridonin was 15.64μM. The results were shown in Table 1 .
Effect of oridonin on SGC-7901 cell cycle
To study roles of oridonin in cell cycle arrest, oridonin was used to test cell cycle on SGC-7901 cell line. The SGC-7901 cells were treated with concentrations of 0.375, 0.75, 1.5μmol/L oridonin for 48h. After treatment, the cells were harvested, and the cell cycle arrest was tested by flow cytometre (Figure 2 ). Quantitative analysis showed that proportion of G 2 /M phase increased from 7.48%±0.46% at control group to 13.87%±0.57%, 14.24%±0.62%, 14.98%±0.69% when the cells were treated with the concentrations of 0.375, 0.75, 1.5μmol/L oridonin, respectively ( Table 2 ). The results showed that oridonin could arrest the SGC-7901 cells in G 2 /M phase.
Effect of oridonin on Cdk1 and CyclinB1 protein expression
To determine whether the Cdk1 protein and CyclinB1 protein are involved in the cell cycle arrest effects of oridonin on SGC-7901 cells, Western blot assay was applied. As shown in Figure 3 and Figure 4 , after 48h of the SGC-7901 cells being exposed to oridonin for different concentrations (0.375, 0.75, 1.5μmol/L), the expression levels of Cdk1 protein and Cyclin B1 protein in SGC-7901 decreased (p<0.01), compared with negative group (show in Figure 3 and Figure 4 ).
Discussion
Gastric cancer is one of the high incidence of tumor. Establishment of effective therapies for stomach cancer is very important for cancer research (Hu et al., 2012) . Although there are a lot of therapeutic options available for patients with tumor, the efficacy is not curative. Cytotoxicity is believed as one of the major goals of cancer chemotherapy. It is thought that arrestting the cell cycle of cancer is important factor in the development of cancer cell (Alabsi et al., 2012; Yang et al., 2013) . Therefore, it appears that exploiting the cell cycle blocker is good idea about anti-cancer drug discovery.
A lot of antitumor drugs were derived from plants or traditional medicine, which were used to treat the disease as different folk medicine for a long time, so new drug discovery from herbs is more likely to succeed (Shin et al., 2012; Huang et al., 2013) . Rabdosia rubescens has been used as an herbal remedy for various ailments including cancer in China, and oridonin is one of the anticancer components of Rabdosia rubescens. The paper was initiated with the purpose of evaluating the action of oridonin on human stomach cancer.
The experimental results show that oridonin had good cytotoxicity against the SGC-7901 cells based on the high IC 50 value as similar as hydroxycamptothecine (Table 1) . Mang documents show that oridonin could block MCF-10A, HepG2, laryngeal carcinoma and other tumor cell cycles (Hsieh et al., 2005; Kang et al., 2010; Wang et al., 2010) . However, there is little report about the SGC-7901. So, this paper explored SGC-7901 from the perspective of cell cycle. The result showed that oridonin in different concentrations could block the SGC-7901 cells in G 2 /M phase.
Cell cycle involves four sequential phases that go from quiescence (G 0 phase) to proliferation (G 1 , S, G 2 , and M phases), by which all living things reproduce. In all eukaryotic cells, including human cells, cell cycling is driven by sequential activation of cyclin-dependent kinases (CDKs) and its cofactor cyclins (Diaz-Moralli et al., 2013) . Among the countless elements taking part in this process, the sequential activation of heterodimeric CDK-cyclin complexes (cyclins and their counterpart cyclin-dependent kinases (CDKs) has been described as the key regulatory events. Cyclin-dependent kinases (CDKs) are a family of mammalian heterodimeric serine/ threonine protein kinases composed of two subunits, the catalytic one known as CDK and the regulatory one known as cyclin (Shapiro, 2006; Malumbres and Barbacid, 2007) . The kinase activity of CDKs is tightly regulated by the binding to cyclins, the activating subunits which are expressed in an oscillatory way, the binding to negative regulators (CDK inhibitors, CKI) and phosphorylation/ dephosphorylation events (Manchado et al., 2012) . Progression through each cell cycle phase and transition from one phase to the next are monitored by sensor mechanisms, called checkpoints, which maintain the accurate sequence of events (Hartwell and Weinert, 1989) .
CDK1-cyclin B complexes are essential for initiating mitosis and can phosphorylate a broad spectrum of proteins involved in regulatory and structural processes required for mitosis such as nuclear envelope breakdown, chromosomal condensation, fragmentation of the Golgi apparatus, formation of the spindle and attachment of chromosomes to it (Malumbres and Barbacid, 2005; Mahadevan et al., 2011) . Exiting mitosis requires the inactivation of CDK1-cyclin B, which is carried out by the ubiquitin-dependent proteolysis of B-type cyclins by the APC/C-CDC20 complex (Harper et al., 2002; Peters, 2002) .
So, cell cycle proteins (cyclinsB1) and cyclindependent protein kinase (Cdk1) were closely related with G 2 /M phase. CyclinB1, as the key factor to switch on mitosis, could compose compound with Cdk1 to adjust the G 2 /M phase.
Our study showed that oridonin arrested the SGC-7901 cell cycle in G 2 /M phase, To explore the relation of G 2 /M phase arrestion to CDK1and cyclin B1, we tested the effect of oridonin on Cdk1 and Cyclin B1 proteins. The results showed that oridonin could significantly decreased the expression of Cdk1 and Cyclin B1 proteins in SGC-7901 cells, which would led to a significant reduction in the formation of CDK1-cyclin B complexes, and then block the cells in G 2 /M phase.
The above analysis showed that oridonin blocked SGC-7901 cells in G 2 /M phase by down-regulating the protein expressions of CDK1, CyclinB1.
